Why it matters: The goal of altering cells with CRISPR, a gene-editing tool, is to treat disease, not cause it. If these new results hold up, they could present an insurmountable roadblock for the development of certain CRISPR-based therapies. They are unlikely to stop all CRISPR-based treatment, however.
Never miss an Axios exclusive. Sign up for Mike Allen's AM newsletter.
More stories loading.